Announced Thu, 2 Jul · 21:53 IST
Shareholders approve amalgamation of Dr. Agarwal's Eye Hospital into listed entity
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹476.00
prior close
₹479.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2-0.4-0.8+0.6-1.3+0.4+1.9+0.6+2.3+1.2———
Up moveDown movePending
AI summary
Shareholders of Dr. Agarwal's Health Care approved the Scheme of Amalgamation with Dr. Agarwal's Eye Hospital (transferor) with 99.97 percent votes in favor (about 30.39 crore shares) at the NCLT convened meeting on July 2, 2026. Only 81,138 shares voted against. The merger will consolidate the eye hospital business into the listed entity, subject to NCLT and other regulatory approvals.
Likely market impact
Positive; internal group restructuring awaiting NCLT sanction. Simplifies structure by merging eye hospital into listed entity.